T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mondelez International
MDLZ
|
+$841M |
| 2 |
Liberty Global Class C
LBTYK
|
+$752M |
| 3 |
Apple
AAPL
|
+$720M |
| 4 |
Tesla
TSLA
|
+$713M |
| 5 |
NXP Semiconductors
NXPI
|
+$648M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$1.2B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.03B |
| 3 |
Gilead Sciences
GILD
|
+$917M |
| 4 |
Pfizer
PFE
|
+$901M |
| 5 |
Nike
NKE
|
+$872M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.88% |
| 2 | Consumer Discretionary | 14.86% |
| 3 | Financials | 14.2% |
| 4 | Technology | 12.51% |
| 5 | Industrials | 9.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
Antero Resources
AR
$11.4B
| $22.8M | ﹤0.01% |
+876,797
| New | +$23.9M |
|
1052
Entegris
ENTG
$25.3B
| $22.8M | ﹤0.01% |
1,572,302
+500
| +0% | +$6.87K |
|
|
WPX
1053
DELISTED
WPX Energy, Inc.
WPX
| $22.6M | ﹤0.01% |
2,422,149
-23,090
| -0.9% | -$208K |
|
|
SIX
1054
DELISTED
Six Flags Entertainment Corp.
SIX
| $22.5M | ﹤0.01% |
388,774
+5,958
| +2% | +$347K |
|
1055
Gentex
GNTX
$4.95B
| $22.5M | ﹤0.01% |
1,456,711
-8,755
| -0.6% | -$139K |
|
1056
NOV
NOV
$7.4B
| $22.5M | ﹤0.01% |
667,807
-30,510
| -4% | -$980K |
|
|
RDC
1057
DELISTED
Rowan Companies Plc
RDC
| $22.4M | ﹤0.01% |
1,270,188
+1,216,195
| +2,253% | +$21.1M |
|
1058
Gen Digital
GEN
$17.2B
| $22.3M | ﹤0.01% |
1,083,968
-107,340
| -9% | -$1.93M |
|
1059
Advance Auto Parts
AAP
$3.34B
| $22.3M | ﹤0.01% |
137,705
+700
| +0.5% | +$108K |
|
1060
Insteel Industries
IIIN
$629M
| $22.2M | ﹤0.01% |
776,757
+82,185
| +12% | +$2.33M |
|
1061
The Ensign Group
ENSG
$10.6B
| $22.2M | ﹤0.01% |
1,128,731
+181,355
| +19% | +$3.62M |
|
|
CBM
1062
DELISTED
Cambrex Corporation
CBM
| $22.1M | ﹤0.01% |
426,500
+20,990
| +5% | +$1M |
|
|
CUB
1063
DELISTED
Cubic Corporation
CUB
| $22M | ﹤0.01% |
548,050
-101,450
| -16% | -$4.12M |
|
1064
Outfront Media
OUT
$5.3B
| $22M | ﹤0.01% |
923,527
+9,683
| +1% | +$212K |
|
1065
YPF Sociedad Anonima American Depositary Shares (Each representing ten (10) Class D shares of Capital Stock)
YPF
$19.1B
| $22M | ﹤0.01% |
1,143,380
+1,000,250
| +699% | +$19.9M |
|
1066
ICU Medical
ICUI
$4.53B
| $21.9M | ﹤0.01% |
194,450
+12,900
| +7% | +$1.34M |
|
1067
Golub Capital BDC
GBDC
$3.45B
| $21.9M | ﹤0.01% |
1,238,606
+1,634
| +0.1% | +$27.7K |
|
1068
PUT
JPMorgan Chase
JPM
$964B
| $21.7M | ﹤0.01% |
350,000
| – | – |
|
|
AKRX
1069
DELISTED
Akorn Inc
AKRX
| $21.6M | ﹤0.01% |
759,712
+190,510
| +33% | +$5.28M |
|
1070
Campbell Soup
CPB
$6.93B
| $21.6M | ﹤0.01% |
325,218
+3,290
| +1% | +$206K |
|
|
RDUS
1071
DELISTED
Radius Health, Inc.
RDUS
| $21.6M | ﹤0.01% |
588,571
+574,011
| +3,942% | +$20.3M |
|
|
CTXS
1072
DELISTED
Citrix Systems Inc
CTXS
| $21.5M | ﹤0.01% |
337,662
-17,343
| -5% | -$1.14M |
|
|
ENDP
1073
DELISTED
Endo International plc
ENDP
| $21.5M | ﹤0.01% |
1,380,245
-1,470,548
| -52% | -$30.5M |
|
|
CCI.PRA
1074
DELISTED
Crown Castle International Corp.
CCI.PRA
| $21.5M | ﹤0.01% |
180,473
-181,340
| -50% | -$19.9M |
|
1075
Liberty Latin America Class A
LILA
$1.67B
| $21.4M | ﹤0.01% |
+1,036,224
| New | +$24.5M |
|
Similar funds
T. Rowe Price Associates's Q2 2016 Portfolio in Review
As of Q2 2016, T. Rowe Price Associates held 2,596 positions worth $472B, up 0.75% from $468B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q2 2016 filing shows 95 new, 1,094 increased, 954 reduced and 84 closed positions. Its largest new stake was American Tower Corporation: 2,223,765 shares worth $246M. The largest sale was Alexion Pharmaceuticals, an estimated $1.2B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2016 buy was American Tower Corporation: 2,223,765 shares worth $246M.
- T. Rowe Price Associates added most to Mondelez International in Q2 2016, an estimated $841M increase.
- T. Rowe Price Associates's biggest Q2 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $1.2B.
- T. Rowe Price Associates fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $750M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $472B portfolio in Q2 2016.
- T. Rowe Price Associates opened 95 new positions and closed 84 in Q2 2016.
- T. Rowe Price Associates's portfolio value rose 0.75% quarter-over-quarter to $472B.
Based on T. Rowe Price Associates's 13F filing for Q2 2016, filed 15 Aug 2016.